Regulation & law · 20/12/2013Updated: 10/17/2026 · 1 min read
Notice of Availability for Licensing of Therapeutic Peptide Invention
Summary
The US Government, represented by the Secretary of the Army, has made available for licensing an invention that inhibits the infectivity of Rift Valley Fever Virus, Ebola Virus, Andes Virus, and Vesicular Stomatitis Virus, as described in a US Provisional Patent Application filed on December 6, 2012.
Original source language: Federal Register — All DocumentsOpen original release →